0001493152-20-002154.txt : 20200212
0001493152-20-002154.hdr.sgml : 20200212
20200212215335
ACCESSION NUMBER: 0001493152-20-002154
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parker Albert P
CENTRAL INDEX KEY: 0001750079
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 20606723
MAIL ADDRESS:
STREET 1: C/O ONCOCYTE CORPORATION
STREET 2: 1010 ATLANTIC AVENUE, SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncocyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-409-7600
MAIL ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20150513
4
1
ownership.xml
X0306
4
2020-02-10
0
0001642380
Oncocyte Corp
OCX
0001750079
Parker Albert P
15 CUSHING
IRVINE
CA
92618
0
1
0
0
Chief Operating Officer
Option to purchase common stock
2.63
2020-02-10
4
A
0
204000
0
A
2030-02-09
Common Stock
204000
204000
D
One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on February 10, 2020 and the balance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the applicable vesting date.
/s/ Albert P. Parker
2020-02-12